Displaying items by tag: department of pathology

A diabetes drug suggests potential therapy for idiopathic pulmonary fibrosis, based on research with human lung fibroblasts and a mouse model of lung fibrosis.
UAB researchers have identified a subgroup of heart failure patients with reductive stress who may be less responsive or even harmed by antioxidants, which could lead to personalized treatment and better outcomes.
The app was designed with the goal of decreasing the confusion experienced by clinicians when ordering lab tests and choosing or managing a patient’s anticoagulation.
The event brings together physicians and researchers working to improve the available treatments, outcomes and recovery times for the disease.
UAB researcher will serve on the Hemostasis and Thrombosis Study Section.
Many cancers are curable if they are detected early, and UAB researchers are exploring ways to use cancer gene discoveries to develop screening tests to improve cancer survival.
Much like other muscles, when the heart works during the normal daytime hours, it needs a period of rest to repair itself.
Research indicates alternative contraception methods may reduce the risk in vulnerable populations.
This award from the AABB honors the top paper published in the journal Transfusion.
UAB gets a CDC grant to set up a sentinel surveillance system to track an antibiotic resistant infectious agent responsible for many cases of pneumonia.
Developers and educators at UAB have developed a solution to meet the challenges of getting educational resources to underserved populations by providing software and hardware programs to better train students in Ethiopia and Zambia.
Low dietary potassium leads to calcified arteries and aortic stiffness, while increased dietary potassium alleviates those undesirable effects in a mouse model, suggesting dietary potassium may protect against heart disease and death from heart disease in humans.
This knowledge can provide targets in the search for novel bone-loss therapeutics to treat osteoporosis.
Hadiyah-Nicole Green, UAB alumna, will be recognized by GE in a Grand Central Station display for research in cancer treatment.
A biomarker, endothelial mitochondrial function, may be useful for early identification of newborn babies at risk for lung disease and could enable novel therapy approaches.
Page 6 of 9